Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 17 Breast Neoplasms 10 Carcinoma, Non-Small-Cell Lung 9 Neoplasm Metastasis 6 Prostatic Neoplasms 5 Melanoma 5 Lung Neoplasms 5 Solid Tumor 3 Pain, Postoperative 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Leukemia, Myeloid, Acute 3 Gastrointestinal Stromal Tumors 3 Colorectal Neoplasms 3 Anxiety Disorders 3 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Pain 2 Glioma 2 Colonic Neoplasms 2 Choledocholithiasis 2 Choledochal Cyst 2 Carcinoma 2 Advanced Solid Tumor 2 Advanced Malignancies 2 cMET-dysregulated Advanced Solid Tumors 1 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1

Interventions

Exercise 35 Therapeutics 30 Modafinil 21 Yoga 17 Surveys and Questionnaires 16 Methylphenidate 16 Psychiatric Rehabilitation 14 Acupuncture Therapy 11 Educational Status 9 Walking 8 Early Intervention, Educational 8 Cognitive Behavioral Therapy 8 Ultraviolet Therapy 7 Control Groups 7 Therapeutic Touch 6 Physical Therapy Modalities 6 Mental Status and Dementia Tests 6 Exercise Therapy 6 Acceptance and Commitment Therapy 6 Sugars 5 Qigong 5 Palliative Care 5 Counseling 5 Standard of Care 4 Saline Solution 4 Methods 4 Epoetin Alfa 4 Dexamethasone 4 Behavior Therapy 4 Acupressure 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Fatigue × Midazolam × Clear all

NCT02317341 2019-03-20

Effect of Ketamine on Fatigue Following Cancer Therapy

National Institutes of Health Clinical Center (CC)

Phase EARLY_PHASE1 Terminated

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡